ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AGL Angle Plc

14.50
0.00 (0.00%)
02 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 14.50 14.00 15.00 14.625 14.50 14.50 592,319 16:14:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 2.19M -20.13M -0.0773 -1.88 37.78M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 14.50p. Over the last year, Angle shares have traded in a share price range of 9.125p to 37.50p.

Angle currently has 260,580,547 shares in issue. The market capitalisation of Angle is £37.78 million. Angle has a price to earnings ratio (PE ratio) of -1.88.

Angle Share Discussion Threads

Showing 30651 to 30669 of 33950 messages
Chat Pages: Latest  1238  1237  1236  1235  1234  1233  1232  1231  1230  1229  1228  1227  Older
DateSubjectAuthorDiscuss
11/1/2024
10:24
Bad timing?.
thehitman1
11/1/2024
10:23
Buys and sells nicely balanced....more stake building by institutional investors hopefully
Keep strong Mr K!

fhmktg
11/1/2024
10:22
Looks like they're gonna go for stops around 20p. That's what I'd do. Keep that powder dry...

Edit : Maybe underway as I type...

boris cobaka
11/1/2024
10:06
When you are young you want wealth

When you are old/er you want health.

Remember that.

It's happening to me right now.

dave4545
11/1/2024
10:05
Good luck Mr K. Hope all goes well.

Without further news it does look like the so will drift a bit.
Exciting times though with various positive developments quite likely.
Stock was horrendously oversold and a definite reversion to mean underway imo. Like the crazy spike to 1.50+ it was then way overbought.
Such is the way with small cap bio tech.

boris cobaka
11/1/2024
10:00
Agree sorry to hear that Mr K...wish you luck btw!

The issue with AGL is that we need a solution which is safe, reliable, and fully approved and until that day the company's ramping based on a test sample of a mere 47 doesn't cut the mustard.

I would have preference for a fully tested and approved solution than run the risk of a USA multi billion dollar class-action lawsuit because the Parsortix System misdiagnosis a cancer.

bones699
11/1/2024
09:27
Have you sold?.
thehitman1
11/1/2024
09:07
What goes up always comes down selling pressure very strong again today quick trade hopefully today . Nearly 3 million shares gone through already watching carfully breaks 21p this will drop fast under 20p very quickly .
goforgold1
11/1/2024
09:02
It's plain as day. The all piled in on the upside and are trying to do the same the other way with CFD/SB shorts. They have seen the track record here of a surge in share price and then a drift
bagpuss67
11/1/2024
08:51
Being traded now i bought 21.88p sell later
goforgold1
11/1/2024
08:41
Did say Someone dumping from yesterday at 3pm
goforgold1
11/1/2024
08:10
Banshee,

Re. your 22415, you have misunderstood the RNS, it's not a question of ctDNA containing mutations not found in CTCs - it's the other way round, mutations found on CTCs (living whole cancer cells) that are missing from ctDNA (fragements of dead cells).

Sequencing of ctDNA is based on cells which have been successfully identified and killed by the immune system/current therapy but we know cancer mutates to escape detection. It appears that sequencing of CTCs is revealing some of these new mutations and that they are suitable targets for existing FDA approved targeted drugs. So I'll ask the same question as before, if you were a physician and your patient had progressed after first or second line therapy and you wanted to consider a targeted treatment, would you rely on sequencing of ctDNA or would you also request CTC analysis if it were possible from the same blood sample?

You can mock all you like but any development that helps to advance understanding of how cancer operates and spreads at a molecular level is to be welcomed IMO.

bermudashorts
11/1/2024
08:06
Wow down 7% in less than 6 minutes o dear
goforgold1
11/1/2024
08:05
Rampers bricking themselves today ... Massive red day inbound
jas2022
11/1/2024
08:05
Total collapse from 3p yesterday FEAR IN HERE NOW . Down it blows .
goforgold1
11/1/2024
08:04
Mms very cleaver shorting it now as they know funding coming .
goforgold1
11/1/2024
07:50
Did he say they were engaging with Illumina ie discussing ways they may woork together. So far Illumina don't seem to have favoured a capture tech and seem agnostic on that. AN will b trying to elbow his way to the front of thier queue on the back of this breakthrough I guess
bagpuss67
11/1/2024
07:49
Dumping started at 3pm yesterday.
goforgold1
11/1/2024
07:48
Expect a lot of dumping more today as people be scared of the Presentation one wrong answer and this will be back down rapidly to 14p . ALL YOU NEED TO ASK ARE YOU RAISING MONEY SIMLLE AS THAT .
goforgold1
Chat Pages: Latest  1238  1237  1236  1235  1234  1233  1232  1231  1230  1229  1228  1227  Older

Your Recent History

Delayed Upgrade Clock